Skip to main content
OpenTrials
Completed

NCT Number: NCT03408028

Therapeutic Intervention Code in a Cognitive Geriatric Unit

The diagnostic and therapeutic progresses, associated with modifications in lifestyle and socio-cultural level of populations, have led to a remarkable increase in life expectancy. At the same time, the increasing medicalization of the individual has eroded the traditional boundaries between health and illness, normal and pathological state. This leads to the patient losing his sense of ownership of his own death. If most patients died at home before the Second World War, 75% of the population dies in hospital or institution at the present date.

Most hospitals and care institutions have developed codes, in multidisciplinary internal consultation, to address the interruption or lack of implementation of treatments that make no sense from a medical point of vue. This avoids therapeutic relentlessness.The code in place within the CHU Brugmann is:

* code A: no therapeutic restriction * code B: not to be resuscitated * code C: not to be intensively treated (no escalation in therapeutic treatments) * code D: best palliative care (progressive de-escalation in therapeutic treatments).

These codes are established in consultation with the patient or his legal representative and are re-evaluated in a multidisciplinary way every week.

Planning a care path and therefore establishing a therapeutic code is particularly important for people with cognitive impairment and dementia because the progressive loss of cognitive abilities complicates the process of decision making.

A large part of the admissions are made via the emergency department. For these patients, no therapeutic plan has been established beforehand. However, the perception of the functional and cognitive status of the patient directly influences the intensity of care provided. Cognitive disorders are a risk factor for the exclusion of access to palliative care for the elderly patient.

The objectives of this study are:

* To establish a record of the therapeutic limitation codes in an acute cognitive geriatric unit * To correlate the therapeutic limitation code with the comorbidities of the patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Brugmann

Brussels, Belgium

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Elderly patients with cognitive impairment admitted in the geriatric unit 83 within the CHU Brugmann between 01-01-2016 and 31-12-2016.

Exclusion criteria

None

Treatment and study plan

Medical File consultation

Other

Medical File consultation

Primary outcomes

  1. Therapeutic code

    Time frame: From 01-01-2016 till 31-12-2016

    Therapeutic code

  2. Cumulative Illness Rating Scale for Geriatrics

    Time frame: From 01-01-2016 till 31-12-2016

    This scoring system measures the chronic medical illness ("morbidity") burden while taking into consideration the severity of chronic diseases in 14 items representing individual body systems. The cumulative final score can theoretically vary from 0 to 56.

Secondary outcomes

  1. Age

    Time frame: From 01-01-2016 till 31-12-2016

    Age

  2. Sex

    Time frame: From 01-01-2016 till 31-12-2016

    Sex

  3. Ethnicity

    Time frame: From 01-01-2016 till 31-12-2016

    Ethnicity

Sponsors and collaborators

Lead sponsor

Murielle Surquin

Other

Registry information

Official study title

Therapeutic Intervention Code in a Cognitive Geriatric Unit: Retrospective Analysis

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jan 23, 2018
Registry last updated
Jan 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.